Amex’s CEO said that recent metrics are “in many cases better than what we saw in 2024.”
Eli Lilly’s stock soars as successful trial of weight-loss pill is a game changer
If approved, the pill is expected to be far easier to administer than current injectables—and far easier to manufacture